Abiomed
Investor profile
Abiomed has backed 3 European tech companies across 3 funding rounds between 2017 and 2018, joining rounds totalling €55M. Most active in Healthtech. Data as of 4 Nov 2026.
Also recorded as: Abiomed Inc.
Deals
3
distinct rounds
Companies
3
backed
Active span
2017–2018
2 yrs
Total round €
€55M
sum of rounds joined
Deals by year
distinct rounds / yearAbiomed — deals by year — interactive chart.
Data table
| Abiomed — deals by year | |
|---|---|
| 2017 | 2 |
| 2018 | 1 |
Top sectors
by dealsAbiomed — top sectors — interactive chart.
Data table
| Abiomed — top sectors | |
|---|---|
| Healthtech | 3 |
Stages
by dealsAbiomed — stages — interactive chart.
Data table
| Abiomed — stages | |
|---|---|
| Series A | 1 |
| Series B | 1 |
| Series C | 1 |
Countries
by dealsAbiomed — countries — interactive chart.
Data table
| Abiomed — countries | |
|---|---|
| Germany | 1 |
| Israel | 1 |
| UK | 1 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared roundsPortfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| ALung Technologies | UK | 1 | €34M |
| Magenta Medical | Israel | 1 | €13M |
| Protembis | Germany | 1 | €8.6M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| ALung Technologies | Series C | €34M | 2017-04 |
| Magenta Medical | Series B | €13M | 2017-08 |
| Protembis | Series A | €8.6M | 2018-10 |